Express Pharma

Jubilant Ingrevia commissions new facility for Diketene and derivatives

The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters

0 105

Jubilant Ingrevia has commissioned a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. The company presently has over 134 products and solutions commercialised. It has developed proficiency across ~35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.

Reportedly, the newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters. “This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives,” informed a company release.

In addition to existing clients the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, including the US and EU regions.

- Advertisement -